Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is not fully prepared for another pandemic or widespread health crisis, though it has made meaningful progress in some areas since COVID-19. Assessments from bipartisan commissions, public health organizations, government watchdogs, CDC/HHS reports, and experts consistently describe improved technical capacities alongside persistent structural gaps, uneven state-level readiness, funding shortfalls, eroded public trust, and incomplete implementation of lessons learned. A major event would still strain the system significantly.[1][2]
Key Improvements Post-COVID
The US has strengthened several foundational elements:
These changes mean the US could detect and initially respond faster in certain technical domains than in early 2020.
Persistent Gaps and Vulnerabilities
Multiple authoritative sources highlight that progress is incomplete and fragile:
Recent real-world tests (H5N1 in dairy cattle/workers, mpox, other outbreaks) revealed ongoing lags in testing, surveillance of zoonoses, and rapid scaling.
Bottom Line and Outlook
The US is better equipped in stockpiles, certain technologies, data systems, and institutional memory than before COVID-19, and it has tools and plans that did not exist then. However, it is not adequately prepared overall. Fragmented leadership, boom-bust funding, workforce/hospital capacity shortfalls, uneven state readiness, supply risks, and especially low public trust create substantial vulnerabilities. A severe or novel pathogen (or deliberate biological event) could again overwhelm systems, cause high excess mortality, and inflict major economic/social damage—particularly if it exploits respiratory transmission, hits vulnerable populations hard, or coincides with other stressors.[2]
Sustained, bipartisan investment in core public health infrastructure, countermeasure R&D/manufacturing, surveillance, workforce, equity-focused planning, and trust-building—plus full implementation of existing recommendations (e.g., from the Biodefense Commission, GAO, TFAH, and CDC frameworks)—would close many gaps. Without that, preparedness will continue to erode between crises. Experts emphasize that another pandemic is a matter of “when,” not “if,” making proactive strengthening a national security priority.
Citations (9)
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Assessments from bipartisan commissions, public health organizations, government watchdogs, CDC/HHS reports, and experts consistently describe improved technical capacities alongside persistent structural gaps, uneven state-level readiness, funding shortfalls, eroded public trust, and incomplete implementation of…”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Assessments from bipartisan commissions, public health organizations, government watchdogs, CDC/HHS reports, and experts consistently describe improved technical capacities alongside persistent structural gaps, uneven state-level readiness, funding shortfalls, eroded public trust, and incomplete implementation of…”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “Domestic manufacturing incentives (e.g., Make PPE in America Act) and BARDA efforts have advanced medical countermeasures, with multiple new FDA approvals.”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “Lab capacity and public-private partnerships for rapid test development advanced.”
- https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/
Backs: “Investments in mRNA/platform technologies for faster vaccine development (goal of 100 days in some visions), expanded Health Care Coalitions, Medical Reserve Corps, and global health security partnerships. Some states score highly on readiness metrics.”
- https://www.govexec.com/oversight/2024/08/agencies-have-only-completed-about-half-gaos-covid-19-recommendations/398626/?oref=ge-topic-lander-river
Backs: “High-risk list items related to public health emergencies persist.”
- https://pandemics.sph.brown.edu/why-did-best-prepared-country-world-fare-so-poorly-during-covid
Backs: “Supply chain vulnerabilities and manufacturing scale-up challenges linger for some countermeasures.”
- https://www.scientificamerican.com/article/on-covids-fifth-anniversary-scientists-reflect-on-mistakes-and-successes/
Backs: “Experts (e.g., Michael Osterholm and others) have stated the US may be less prepared in social/political dimensions than in 2020.”
- https://www.who.int/publications/i/item/9789240105409
Backs: “WHO Joint External Evaluation (2024) of US IHR capacities noted strengths but recommended better alignment across federal/state/local/tribal/territorial levels, workforce sustainability, funding efficiency, community trust, and equity.”